North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher. The ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately ... Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories (NYSE:ABT – Get Free Report ... They set an “outperform” rating and a $130.00 price objective on the stock. Piper Sandler upped their price target on Abbott Laboratories ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

As of 22 January at 9:39:08 GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.